Astrotech Corporation (ASTC) AI Stock Analysis
ASTC AI stock analysis summary
AI ResearchAstrotech Corporation is a developer and licensor of mass spectrometry technologies, serving security, agricultural, and health testing markets. In FY2026, revenue fell 13.0% to $913,000, contributing to a net loss of -$14.4M and negative operating cash flow of -$13.5M. The company maintains a net cash position of $9.0M with a market capitalization of $10.4M as of October 16, 2026.
- Market cap
- $10.4M
- Revenue (TTM)
- $913,000
- P/E
- — fwd 10.2x
- 1Y return
- 21.4% S&P 500 16.8%
- Avg. target
- —
Bull case
- Astrotech holds $11.3M in cash and short-term investments with just $2.3M in debt, resulting in a net cash position of $9.0M.
- The stock delivered a 1-year return of 21.4%, outpacing the S&P 500 ETF return of 16.8%.
- Gross margin improved to 23.8% in FY2026 after falling to -64.9% in FY2025.
Bear case
- Free cash flow was -$14.3M in FY2026, driven by an operating cash outflow of -$13.5M against just $913,000 in revenue.
- Net loss widened to -$14.4M in FY2026, producing a trailing twelve-month operating margin of -2577.8%.
- Quarterly revenue growth for the period ended June 30, 2026, dropped 42.7% year-over-year.
What Astrotech does
Astrotech Corporation specializes in the ownership and licensing of intellectual property related to its Astrotech Mass Spectrometer Technology platform. Its flagship TRACER 1000 is an explosive trace detector designed for security checkpoints at airports, cargo facilities, borders, and secured locations. The company also develops market-specific analytical instruments, including the AgLAB-1000 for quality assurance and regulatory compliance in hemp and cannabis, and the BreathTest-1000 for detecting volatile organic compound metabolites in human breath. Founded in 1984 as SPACEHAB, Inc. and rebranded in 2009, the Austin, Texas-based company operates with 28 employees.
Growth and profitability
Astrotech generated $913,000 in revenue for FY2026, down 13.0% from $1.0M in FY2025 and below its FY2024 peak of $1.7M, though its 5-year revenue CAGR from FY2021 to FY2026 was 22.3%. Gross margin rebounded to 23.8% in FY2026 after dropping to -64.9% in FY2025. Operating margin remained deeply negative at -1548.5% in FY2026, compared to -1404.6% in FY2025. Net loss expanded to -$14.4M, or -$8.49 per share, in FY2026, compared to -$13.8M in FY2025 and -$11.7M in FY2024. For the trailing twelve months ended June 30, 2026, revenue stood at $913,000 with quarterly revenue declining 42.7% year-over-year.
Balance sheet and cash flow
As of June 30, 2026, Astrotech held $11.3M in cash and short-term investments against total debt of $2.3M, leaving net cash of $9.0M. Total assets were $20.5M and shareholders' equity was $16.2M. Liquidity is supported by a current ratio of 7.06 and a debt-to-equity ratio of 0.14. Operating cash flow was -$13.5M and free cash flow was -$14.3M in FY2026, with capital expenditures of $879,000. Over five years, the company's share count increased by 12.9%.
Valuation and performance
Astrotech trades at a price-to-sales multiple of 11.3x and an enterprise value-to-revenue multiple of 10.5x, compared to a median price-to-sales multiple of 2.8x for its US-listed Technology peers. Its EV to EBITDA stands at 16.6x, matching the median of its US-listed Technology peers. The forward P/E ratio is 10.2x, below the sector peer median forward P/E of 18.8x. Astrotech stock gained 21.4% over the past year, outperforming the S&P 500 ETF (SPY) return of 16.8%, but is down 83.2% over five years versus an 83.0% gain for the S&P 500.
What analysts expect
Astrotech has an upcoming earnings date scheduled for November 12, 2026. The stock closed at $4.93 on October 16, 2026, which is 30.9% below its 200-day moving average and well off its 52-week high of $68.85.
Key risks and what to watch
- Cash burn remains elevated, with free cash flow of -$14.3M in FY2026 exceeding the cash balance of $11.3M as of June 30, 2026.
- The stock has a beta of 4.92 and has traded between a 52-week low of $1.92 and a 52-week high of $68.85.
- Dilution risk exists, as the 5-year share count change shows an increase of 12.9%.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this ASTC AI stock analysis
This page is an AI-written research summary of Astrotech Corporation (ASTC). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: ASTC income statement, ASTC balance sheet, ASTC key metrics, ASTC chart. See the ASTC stock overview for the latest quote and news.
ASTC AI stock analysis FAQ
What does Astrotech Corporation do?
Astrotech Corporation develops and licenses mass spectrometry technology. Its products include the TRACER 1000 for explosive trace detection, the AgLAB-1000 for hemp and cannabis testing, and the BreathTest-1000 for human breath analysis.
Does Astrotech pay a dividend?
Astrotech does not pay a dividend. The company recorded negative free cash flow of -$14.3M in FY2026.
How much debt does Astrotech have?
As of June 30, 2026, Astrotech had $2.3M in total debt and $11.3M in cash and short-term investments, resulting in net cash of $9.0M and a debt-to-equity ratio of 0.14.
When does Astrotech report earnings next?
Astrotech's next earnings date is November 12, 2026.